From Exponential Growth to PHARMA BOOM biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.
Glenmark Pharma reports consolidated revenue growth of 6 3 per cent and adjusted EBITDA growth of 8 3 per cent YoY for Q2 FY 2023-24 aninews.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aninews.in Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The Global Chlor-Alkali Market is projected to grow at a CAGR of 3.57% from 2023 to 2030, according to a new report published by Verified.
NL Corresspondent Jammu Tawi: In a successful bid, Nirma Group has entered into definitive agreement to acquire 75% of Glenmark Life Sciences Limited from Glenmark Pharmaceuticals Limited at an enterprise value of about INR 7,500 Crore, subject to closing adjustments. Nirma will make a mandatory open offer as per SEBI Regulations. This acquisition is subject